283 related articles for article (PubMed ID: 12921244)
1. Effects of grapefruit juice on intestinal P-glycoprotein: evaluation using digoxin in humans.
Parker RB; Yates CR; Soberman JE; Laizure SC
Pharmacotherapy; 2003 Aug; 23(8):979-87. PubMed ID: 12921244
[TBL] [Abstract][Full Text] [Related]
2. Effect of grapefruit juice on digoxin pharmacokinetics in humans.
Becquemont L; Verstuyft C; Kerb R; Brinkmann U; Lebot M; Jaillon P; Funck-Brentano C
Clin Pharmacol Ther; 2001 Oct; 70(4):311-6. PubMed ID: 11673746
[TBL] [Abstract][Full Text] [Related]
3. Grapefruit juice ingestion significantly reduces talinolol bioavailability.
Schwarz UI; Seemann D; Oertel R; Miehlke S; Kuhlisch E; Fromm MF; Kim RB; Bailey DG; Kirch W
Clin Pharmacol Ther; 2005 Apr; 77(4):291-301. PubMed ID: 15903127
[TBL] [Abstract][Full Text] [Related]
4. Influence of grapefruit juice on the systemic availability of itraconazole oral solution in healthy adult volunteers.
Gubbins PO; McConnell SA; Gurley BJ; Fincher TK; Franks AM; Williams DK; Penzak SR; Saccente M
Pharmacotherapy; 2004 Apr; 24(4):460-7. PubMed ID: 15098799
[TBL] [Abstract][Full Text] [Related]
5. Coadministration of grapefruit juice increases systemic exposure of diltiazem in healthy volunteers.
Christensen H; Asberg A; Holmboe AB; Berg KJ
Eur J Clin Pharmacol; 2002 Nov; 58(8):515-20. PubMed ID: 12451428
[TBL] [Abstract][Full Text] [Related]
6. Grapefruit juice markedly increases the plasma concentrations and antiplatelet effects of ticagrelor in healthy subjects.
Holmberg MT; Tornio A; Joutsi-Korhonen L; Neuvonen M; Neuvonen PJ; Lassila R; Niemi M; Backman JT
Br J Clin Pharmacol; 2013 Jun; 75(6):1488-96. PubMed ID: 23126367
[TBL] [Abstract][Full Text] [Related]
7. 6',7'-Dihydroxybergamottin in grapefruit juice and Seville orange juice: effects on cyclosporine disposition, enterocyte CYP3A4, and P-glycoprotein.
Edwards DJ; Fitzsimmons ME; Schuetz EG; Yasuda K; Ducharme MP; Warbasse LH; Woster PM; Schuetz JD; Watkins P
Clin Pharmacol Ther; 1999 Mar; 65(3):237-44. PubMed ID: 10096255
[TBL] [Abstract][Full Text] [Related]
8. Intestinal drug transporter expression and the impact of grapefruit juice in humans.
Glaeser H; Bailey DG; Dresser GK; Gregor JC; Schwarz UI; McGrath JS; Jolicoeur E; Lee W; Leake BF; Tirona RG; Kim RB
Clin Pharmacol Ther; 2007 Mar; 81(3):362-70. PubMed ID: 17215845
[TBL] [Abstract][Full Text] [Related]
9. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine.
Dresser GK; Bailey DG; Leake BF; Schwarz UI; Dawson PA; Freeman DJ; Kim RB
Clin Pharmacol Ther; 2002 Jan; 71(1):11-20. PubMed ID: 11823753
[TBL] [Abstract][Full Text] [Related]
10. Exposure-dependent inhibition of intestinal and hepatic CYP3A4 in vivo by grapefruit juice.
Veronese ML; Gillen LP; Burke JP; Dorval EP; Hauck WW; Pequignot E; Waldman SA; Greenberg HE
J Clin Pharmacol; 2003 Aug; 43(8):831-9. PubMed ID: 12953340
[TBL] [Abstract][Full Text] [Related]
11. Variation in oral clearance of saquinavir is predicted by CYP3A5*1 genotype but not by enterocyte content of cytochrome P450 3A5.
Mouly SJ; Matheny C; Paine MF; Smith G; Lamba J; Lamba V; Pusek SN; Schuetz EG; Stewart PW; Watkins PB
Clin Pharmacol Ther; 2005 Dec; 78(6):605-18. PubMed ID: 16338276
[TBL] [Abstract][Full Text] [Related]
12. Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: comparison with grapefruit juice.
Bailey DG; Dresser GK; Bend JR
Clin Pharmacol Ther; 2003 Jun; 73(6):529-37. PubMed ID: 12811362
[TBL] [Abstract][Full Text] [Related]
13. Effects of grapefruit and Seville orange juices on the pharmacokinetic properties of colchicine in healthy subjects.
Wason S; DiGiacinto JL; Davis MW
Clin Ther; 2012 Oct; 34(10):2161-73. PubMed ID: 22940371
[TBL] [Abstract][Full Text] [Related]
14. The effect of grapefruit juice and seville orange juice on the pharmacokinetics of dextromethorphan: the role of gut CYP3A and P-glycoprotein.
Di Marco MP; Edwards DJ; Wainer IW; Ducharme MP
Life Sci; 2002 Jul; 71(10):1149-60. PubMed ID: 12095536
[TBL] [Abstract][Full Text] [Related]
15. Grapefruit juice-drug interactions: Grapefruit juice and its components inhibit P-glycoprotein (ABCB1) mediated transport of talinolol in Caco-2 cells.
de Castro WV; Mertens-Talcott S; Derendorf H; Butterweck V
J Pharm Sci; 2007 Oct; 96(10):2808-17. PubMed ID: 17542018
[TBL] [Abstract][Full Text] [Related]
16. Grapefruit juice reduces the oral bioavailability of fexofenadine but not desloratadine.
Banfield C; Gupta S; Marino M; Lim J; Affrime M
Clin Pharmacokinet; 2002; 41(4):311-8. PubMed ID: 11978146
[TBL] [Abstract][Full Text] [Related]
17. Duration of effect of grapefruit juice on the pharmacokinetics of the CYP3A4 substrate simvastatin.
Lilja JJ; Kivistö KT; Neuvonen PJ
Clin Pharmacol Ther; 2000 Oct; 68(4):384-90. PubMed ID: 11061578
[TBL] [Abstract][Full Text] [Related]
18. Further characterization of a furanocoumarin-free grapefruit juice on drug disposition: studies with cyclosporine.
Paine MF; Widmer WW; Pusek SN; Beavers KL; Criss AB; Snyder J; Watkins PB
Am J Clin Nutr; 2008 Apr; 87(4):863-71. PubMed ID: 18400708
[TBL] [Abstract][Full Text] [Related]
19. Grapefruit juice enhances the exposure to oral oxycodone.
Nieminen TH; Hagelberg NM; Saari TI; Neuvonen M; Neuvonen PJ; Laine K; Olkkola KT
Basic Clin Pharmacol Toxicol; 2010 Oct; 107(4):782-8. PubMed ID: 20406214
[TBL] [Abstract][Full Text] [Related]
20. Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression.
Lown KS; Bailey DG; Fontana RJ; Janardan SK; Adair CH; Fortlage LA; Brown MB; Guo W; Watkins PB
J Clin Invest; 1997 May; 99(10):2545-53. PubMed ID: 9153299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]